HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Berl R Oakley Selected Research

asperthecin

1/2014Inhibition of Tau aggregation by three Aspergillus nidulans secondary metabolites: 2,ω-dihydroxyemodin, asperthecin, and asperbenzaldehyde.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Berl R Oakley Research Topics

Disease

3Neurodegenerative Diseases (Neurodegenerative Disease)
01/2021 - 01/2014
3Alzheimer Disease (Alzheimer's Disease)
01/2021 - 01/2014
3Neoplasms (Cancer)
08/2020 - 09/2015
1Pneumonia (Pneumonitis)
01/2020
1Cystic Fibrosis (Mucoviscidosis)
01/2020
1Breast Neoplasms (Breast Cancer)
01/2020
1Onychomycosis (Tinea Unguium)
05/2016
1Infections
05/2016
1Tauopathies
01/2014
1Mycoses (Diseases, Fungus)
01/2013
1Osteoporosis
07/2009

Drug/Important Bio-Agent (IBA)

2Microtubule-Associated Proteins (Microtubule-Associated Protein 2)IBA
05/2015 - 01/2014
1Amyloid (Amyloid Fibrils)IBA
01/2021
1Liposomes (Liposome)IBA
08/2020
1Pharmaceutical PreparationsIBA
05/2016
1TubulinIBA
09/2015
1asperthecinIBA
01/2014
1asperbenzaldehydeIBA
01/2014
1Emodin (Archin)IBA
07/2009
1PolyketidesIBA
07/2009

Therapy/Procedure

2Therapeutics
01/2017 - 01/2014
2Drug Therapy (Chemotherapy)
05/2016 - 01/2013
1Lung Transplantation
01/2020